Organic Chemistry

A 1-pot synthesis of the SARS-CoV-2 Mpro Inhibitor Nirmatrelvir, the key ingredient in Paxlovid

Authors

Abstract

A newly devised route to the Pfizer drug nirmatrelvir is reported that reduces the overall sequence to a 1-pot process and relies on a commercially available, green coupling reagent, T3P. The overall yield of the targeted material, isolated as its MTBE solvate, is 53%.

Content

Thumbnail image of Nirmatrelvir_T3P_ms_9-13-22.pdf

Supplementary material

Thumbnail image of SI.pdf
Supporting Information
Optimization of reaction protocols and NMR, HRMS, and HPLC data of isolated compounds.